Type II cGMP-dependent protein kinase inhibits RhoA activation in gastric cancer cells

被引:8
|
作者
Wang, Ying [1 ]
Chen, Yongchang [1 ]
Li, Yueying [1 ]
Lan, Ting [1 ]
Qian, Hai [1 ]
机构
[1] Jiangsu Univ, Sch Med Sci & Lab Med, Dept Physiol, Zhenjiang 212013, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
inhibition; type II cGMP-dependent protein kinase; gastric cancer cells; RhoA; PHOSPHORYLATION; PROLIFERATION; MIGRATION; GTPASES; APOPTOSIS;
D O I
10.3892/mmr.2014.1960
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Small GTPase RhoA is a key signaling component regulating cell migration and stress fiber formation. Previous studies have shown that RhoA activity is regulated by protein kinases, such as cAMP-dependent protein kinase (PKA) and type I cGMP-dependent protein kinase (PKGI), which phosphorylate the protein. This study was designed to investigate the effect of type II cGMP-dependent protein kinase (PKGII) on RhoA activity. Cells of the human gastric cancer line AGS were infected with adenoviral constructs bearing the PKGII cDNA in order to increase its endogenous expression, and were treated with 8-pCPT-cGMP to activate the PKGII enzyme. A transwell assay was performed to measure the migratory activity of the treated cells, and immunofluorescent microscopy was used to observe the formation of stress fibers. The phosphorylation of RhoA was detected by western blotting, and the activity of RhoA was measured by a pull-down assay. Co-immunoprecipitation (co-IP) was performed to detect binding of PKGII to RhoA. Glutathione S-transferase (GST)-fused fragments of RhoA and PKGII were expressed in Escherichia coli and used to investigate the domains required for the binding. The results showed that lysophosphatidic acid (LPA) treatment increased the migration and the formation of stress fibers in AGS cells and that this effect was RhoA-dependent. An increase in PKGII activity, not only inhibited LPA-induced migration and stress fiber formation, but also suppressed LPA-induced activation of RhoA. PKGII caused serine 188 (Ser188) phosphorylation of RhoA, but not the phosphorylation of the mutant RhoA Ser188A, and therefore had no inhibitory effect on the activity of the mutant protein. Co-IP results showed that there is direct binding of PKGII to RhoA. The GST pull-down assay showed that the fragment containing RhoA amino acid residues 1-44 and the N-terminal fragment of PKGII containing amino acid residues 1-176 are required for the binding between the two proteins. These results suggested that PKGII inhibits RhoA activity by binding to this small GTPase and causing phosphorylation at its Ser188 site.
引用
收藏
页码:1444 / 1452
页数:9
相关论文
共 50 条
  • [1] Type II cGMP-dependent protein kinase directly inhibits HER2 activation of gastric cancer cells
    Zhu, Miaolin
    Yao, Xiaoyuan
    Wu, Min
    Qian, Hai
    Wu, Yan
    Chen, Yongchang
    MOLECULAR MEDICINE REPORTS, 2016, 13 (02) : 1909 - 1913
  • [2] Type II cGMP-dependent protein kinase inhibits activation of key members of the RTK family in gastric cancer cells
    Jiang, Lu
    Chen, Yongchang
    Sang, Jianrong
    Li, Yueying
    Lan, Ting
    Wang, Ying
    Tao, Yan
    Qian, Hai
    BIOMEDICAL REPORTS, 2013, 1 (03) : 399 - 404
  • [3] Type II cGMP-dependent protein kinase inhibits ligand-induced activation of EGFR in gastric cancer cells
    Jiang, Lu
    Chen, Yongchang
    Li, Yueying
    Lan, Ting
    Wu, Min
    Wang, Ying
    Qian, Hai
    MOLECULAR MEDICINE REPORTS, 2014, 9 (04) : 1405 - 1409
  • [4] Type II cGMP-dependent protein kinase inhibits ERK/JNK-mediated activation of transcription factors in gastric cancer cells
    Sang, Jianrong
    Chen, Yongchang
    Jiang, Lu
    Tao, Yan
    Wu, Yan
    Wang, Ying
    Li, Yueying
    Lan, Ting
    Shao, Genbao
    MOLECULAR MEDICINE REPORTS, 2012, 6 (05) : 1190 - 1194
  • [5] Type II cGMP-dependent protein kinase inhibits EGF-induced JAK/STAT signaling in gastric cancer cells
    Wu, Min
    Wu, Yan
    Lan, Ting
    Jiang, Lu
    Qian, Hai
    Chen, Yongchang
    MOLECULAR MEDICINE REPORTS, 2016, 14 (02) : 1849 - 1856
  • [6] Type II cGMP-dependent protein kinase inhibits proliferation of the gastric cancer cell line BGC-823
    Chen, Yong-Chang
    Ren, Feng
    Sang, Jian-Rong
    Tao, Yan
    Xu, Wen-Rong
    MOLECULAR MEDICINE REPORTS, 2010, 3 (02) : 361 - 366
  • [7] Secretory type II cGMP-dependent protein kinase blocks activation of PDGFRβ via Ser254 in gastric cancer cells
    Pang, Ji
    Li, Guorui
    Qian, Hai
    Wu, Yan
    Chen, Yongchang
    CELL BIOLOGY INTERNATIONAL, 2022, 46 (05) : 747 - 754
  • [8] Autophosphorylation of cGMP-dependent protein kinase type II
    Vaandrager, AB
    Hogema, BM
    Edixhoven, M
    van den Burg, CMM
    Bot, AGM
    Klatt, P
    Ruth, P
    Hofmann, F
    Van Damme, J
    Vandekerckhove, J
    de Jonge, HR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (31) : 28651 - 28658
  • [9] cGMP-dependent protein kinase phosphorylates and inactivates RhoA
    Sawada, N
    Itoh, H
    Yamashita, J
    Doi, K
    Inoue, M
    Masatsugu, K
    Fukunaga, Y
    Sakaguchi, S
    Sone, M
    Yamahara, K
    Yurugi, T
    Nakao, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 280 (03) : 798 - 805
  • [10] Type II cGMP-dependent protein kinase inhibits the migration, invasion and proliferation of several types of human cancer cells
    Wu, Min
    Wu, Yan
    Qian, Hai
    Tao, Yan
    Pang, Ji
    Wang, Ying
    Chen, Yongchang
    MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 5729 - 5737